JP6050337B2 - プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 - Google Patents

プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 Download PDF

Info

Publication number
JP6050337B2
JP6050337B2 JP2014514556A JP2014514556A JP6050337B2 JP 6050337 B2 JP6050337 B2 JP 6050337B2 JP 2014514556 A JP2014514556 A JP 2014514556A JP 2014514556 A JP2014514556 A JP 2014514556A JP 6050337 B2 JP6050337 B2 JP 6050337B2
Authority
JP
Japan
Prior art keywords
subject
respiratory tract
upper respiratory
nthi
omp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014514556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014523525A (ja
JP2014523525A5 (enExample
Inventor
スビノイ ダス，
スビノイ ダス，
ローレン オー． バカレッツ，
ローレン オー． バカレッツ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Original Assignee
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University filed Critical Ohio State University
Publication of JP2014523525A publication Critical patent/JP2014523525A/ja
Publication of JP2014523525A5 publication Critical patent/JP2014523525A5/ja
Application granted granted Critical
Publication of JP6050337B2 publication Critical patent/JP6050337B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/14—Disorders of ear, nose or throat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
JP2014514556A 2011-06-06 2012-06-05 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 Active JP6050337B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161493829P 2011-06-06 2011-06-06
US61/493,829 2011-06-06
PCT/US2012/040910 WO2012170422A1 (en) 2011-06-06 2012-06-05 Proteomics based diagnostic detection method for chronic sinusitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016160374A Division JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Publications (3)

Publication Number Publication Date
JP2014523525A JP2014523525A (ja) 2014-09-11
JP2014523525A5 JP2014523525A5 (enExample) 2015-07-23
JP6050337B2 true JP6050337B2 (ja) 2016-12-21

Family

ID=46208851

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014514556A Active JP6050337B2 (ja) 2011-06-06 2012-06-05 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法
JP2016160374A Pending JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016160374A Pending JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Country Status (9)

Country Link
US (4) US9568472B2 (enExample)
EP (1) EP2718722B1 (enExample)
JP (2) JP6050337B2 (enExample)
AU (1) AU2012268380C1 (enExample)
CA (1) CA2838488C (enExample)
DK (1) DK2718722T3 (enExample)
ES (1) ES2649370T3 (enExample)
PL (1) PL2718722T3 (enExample)
WO (1) WO2012170422A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103687613A (zh) * 2011-05-11 2014-03-26 里斯贝克保健瑞典股份公司 蛋白f-具有层粘连蛋白和玻连蛋白结合性能的新的流感嗜血杆菌粘附素
EP2718722B1 (en) * 2011-06-06 2017-10-18 Nationwide Children's Hospital, Inc. Proteomics based diagnostic detection method for chronic sinusitis
JP2015508755A (ja) * 2012-02-01 2015-03-23 オクラホマ メディカル リサーチ ファウンデーションＯｋｌａｈｏｍａ Ｍｅｄｉｃａｌ Ｒｅｓｅａｒｃｈｆｏｕｎｄａｔｉｏｎ ヒト肺炎連鎖球菌抗体およびその使用
CN105979779A (zh) * 2013-08-16 2016-09-28 俄亥俄州国家创新基金会 调整dna甲基化的组合物和方法
US9606118B2 (en) * 2015-03-30 2017-03-28 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of sinusitis
US10921320B2 (en) 2015-03-30 2021-02-16 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis
US11650213B2 (en) 2015-03-30 2023-05-16 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of viral and bacterial infections
CA3057853A1 (en) 2017-03-28 2018-10-04 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0664065B2 (ja) * 1985-12-23 1994-08-22 日水製薬株式会社 菌体外膜保有菌の免疫学的測定法
US5763262A (en) 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
KR910014706A (ko) 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US20020164354A1 (en) 1998-09-30 2002-11-07 Barenkamp Stephen J. High molecular weight surface proteins of non-typeable haemphilus
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
ATE527059T1 (de) * 2004-03-18 2011-10-15 Nissui Pharm Co Ltd Methode zur herstellung einer analytischen vorrichtung und kit
WO2010079739A1 (ja) * 2009-01-07 2010-07-15 大塚製薬株式会社 全インフルエンザ菌の測定方法
US8617574B2 (en) * 2009-02-13 2013-12-31 Valneva Austria Gmbh Nontypable Haemophilus influenzae antigens
US20120276145A1 (en) * 2011-03-28 2012-11-01 House Research Institute Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
EP2718722B1 (en) * 2011-06-06 2017-10-18 Nationwide Children's Hospital, Inc. Proteomics based diagnostic detection method for chronic sinusitis

Also Published As

Publication number Publication date
US20190324037A1 (en) 2019-10-24
AU2012268380B2 (en) 2017-01-05
CA2838488C (en) 2020-06-30
DK2718722T3 (en) 2018-01-15
WO2012170422A1 (en) 2012-12-13
US20170184589A1 (en) 2017-06-29
EP2718722A1 (en) 2014-04-16
US20140314876A1 (en) 2014-10-23
US20190004046A1 (en) 2019-01-03
ES2649370T3 (es) 2018-01-11
JP2014523525A (ja) 2014-09-11
US10048261B2 (en) 2018-08-14
US9568472B2 (en) 2017-02-14
AU2012268380A1 (en) 2014-01-16
EP2718722B1 (en) 2017-10-18
JP2016194532A (ja) 2016-11-17
PL2718722T3 (pl) 2018-04-30
CA2838488A1 (en) 2012-12-13
AU2012268380C1 (en) 2017-03-23
US10725040B2 (en) 2020-07-28
US10345300B2 (en) 2019-07-09

Similar Documents

Publication Publication Date Title
US10725040B2 (en) Proteomics based diagnostic detection method for chronic sinusitis
ES2976232T3 (es) Métodos y dispositivos mejorados para un diagnóstico exacto de infecciones
Schuster et al. Coupling immuno-magnetic capture with LC–MS/MS (MRM) as a sensitive, reliable, and specific assay for SARS-CoV-2 identification from clinical samples
Liu et al. Clinical significance of serum S100A12 in acute otitis media in young children
WO2016161413A1 (en) Urinary tract infection biomarkers
CN107356757B (zh) 一种口腔鳞癌早期诊断试剂、试剂盒、检测方法及应用
TWI522367B (zh) Urine biomarkers are used to predict bladder and kidney cancer
BR102014004679B1 (pt) método preditivo para diagnóstico diferencial de meningites in vitro, uso de proteínas biomarcadoras, e, kit para diagnóstico diferencial de meningites para determinar se um indivíduo possui meningites bacterianas ou meningites virais
EP3137908A2 (en) Methods and compositions for diagnosis and treatment of meningitis
CN102788883A (zh) 一种用于检测抑郁症的试剂盒
KR102515934B1 (ko) 비감염성 폐질환 진단을 위한 바이오마커로서 cd20의 용도
CN105241986A (zh) 区分儿童潜伏结核感染者和活动性结核病患者的蛋白特征谱
US20080213800A1 (en) Method for Examing Interstitital Cystitis
US20130005836A1 (en) Composition and methods related to s100 a2
Tirone et al. Correlation of levels of α–defensins determined by HPLC-ESI-MS in bronchoalveolar lavage fluid with the diagnosis of pneumonia in premature neonates
CN113366012A (zh) 幽门螺杆菌菌株的鉴定方法及鉴定试剂盒
TWI536017B (zh) Detection of hemolytic uremia by using serum fetuin A as a biomarker to detect streptococcus pneumoniae infection
Zhou et al. Plasma exosomes reveal insights into bovine tuberculosis pathogenesis and diagnostic opportunities
US9261504B1 (en) Method and kit for detection of hemolytic uremic syndrome and necrotizing pneumonia in children with pneumococcal disease using serum fetuin-A levels as a biomarker
KR20200015276A (ko) 쯔쯔가무시균 유래 엑소좀을 이용한 쯔쯔가무시병의 진단방법
Mutavhatsindi et al. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis
CN107043413A (zh) 一种肺结核相关的尿液生物标志蛋白及其应用
CN120948813A (zh) Ifi27蛋白作为用于甄别急性呼吸道病毒感染和非病毒感染的标志物的应用
EP2833148A1 (en) Method for determining severity of pneumococcal pneumonia
KR20160073699A (ko) 폐렴환자 소변에서 발굴된 폐렴연쇄상구균 진단용 바이오마커

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150601

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161027

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161124

R150 Certificate of patent or registration of utility model

Ref document number: 6050337

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250